Serguei Nabirotchkine
Oprichter bij PHARNEXT SCA
Oorsprong van het eerstegraads netwerk van Serguei Nabirotchkine
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
44
| Public Company | Biotechnology | 44 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Serguei Nabirotchkine via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree Graduate Degree Masters Business Admin | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Chief Executive Officer | |
| DEINOVE | Biotechnology | Founder Director/Board Member | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CARMAT | Medical Specialties | Founder Director/Board Member | |
| ABIVAX | Pharmaceuticals: Other | Founder Chief Executive Officer | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | Corporate Officer/Principal Chairman | |
| EOS IMAGING | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| Ecole Nationale d'Administration | College/University | Masters Business Admin Undergraduate Degree | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| Philipps University of Marburg | College/University | Doctorate Degree Doctorate Degree | |
| ESCP Europe Campus Paris | College/University | Corporate Officer/Principal | |
PX Therapeutics SA
 PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France. | Miscellaneous Commercial Services | Director/Board Member | |
| ESSEC Business School | College/University | Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| Société des Membres de la Légion d'Honneur | Director/Board Member | ||
| Harvard Business School | College/University | Masters Business Admin | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer | |
| G5 | Chairman | ||
| Suraypharm SAS | Chairman | ||
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chief Executive Officer | |
| Thunderbird School of Global Management | College/University | Graduate Degree | |
| Ecole Spéciale des Travaux Publics | College/University | Undergraduate Degree | |
| IPSEN | Pharmaceuticals: Major | Chairman | |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Chairman | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Chairman | |
| Vectorlab GmbH | Chairman | ||
| Weill Cornell Medical College | College/University | Doctorate Degree | |
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
| ADVICENNE | Pharmaceuticals: Generic | Chairman | |
Silence Therapeutics GmbH
 Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Biotechnology | Chief Executive Officer | |
| AKARI THERAPEUTICS, PLC | Biotechnology | Chief Executive Officer | |
Sund Capital ApS
 Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer | |
| The Cass Foundation | Director/Board Member | ||
| TXCELL | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 22 |
| Verenigde Staten | 11 |
| Verenigd Koninkrijk | 7 |
| België | 6 |
| Zwitserland | 4 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 13 |
| Commercial Services | 7 |
| Finance | 3 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 217 |
| Chairman | 87 |
| Corporate Officer/Principal | 61 |
| Chief Executive Officer | 60 |
| Founder | 51 |
Sterkste connecties
| Insiders | |
|---|---|
| Philippe Pouletty | 51 |
| Hugo Brugière | 33 |
| Philippe Chambon | 31 |
| Marc M. P. de Garidel | 31 |
| Pierre Bastid | 29 |
| Michel de Rosen | 28 |
| Lawrence Steinman | 26 |
| James Kuo | 24 |
| David Solomon | 22 |
| David Stout | 19 |
| Piers John Morgan | 18 |
| Jacques Attali | 18 |
| Lena Elisabeth Svanberg | 16 |
| Nabil Sakkab | 14 |
| René Goedkoop | 12 |
- Beurs
- Insiders
- Serguei Nabirotchkine
- Bedrijfsconnecties
